Solutions for Viral Research Workflows

Viral diseases can attack and spread quickly as seen with COVID-19. To regain control over transmission and accelerate vaccine development, scientists must be prepared with the adequate tools to produce reliable, quality results for viral identification. More specifically scientists must be able to isolate viral particles to study their morphological and genotypic state to push towards vaccine production and biopharma manufacturing.

Download this app note to discover a selection of solutions targeting:

• Sample collection, isolation and preparation
• Antibody analysis
• Vaccine manufacturing and QA/QC